NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM2147867 Query DataSets for GSM2147867
Status Public on May 10, 2016
Title Sample siRNA against the MYC gene [1M]
Sample type SRA
 
Source name Ascitic fluid of an intestinal-type GC
Organism Homo sapiens
Characteristics sirna: MYC gene
cell line: AGP01
passages: Stomach
Treatment protocol An amount of 3x105 cells were seeded into 6cm² plates for each cell line before transfection. Cells were cultured for 24h until cell density was around 50%. A pool or four different double-stranded small interfering RNAs (siRNA) targeting MYC (20 µM, SMARTpool ON-TARGETplus MYC siRNA L-003282-02-0020, Dharmacon, EUA) or scrambled control siRNAs (ON-TARGETplus Non-targeting Pool D-001810-10-05, Dharmacon, GE Lifesciences, EUA) were transfected into AGP01, ACP02 and ACP03 cell lines using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies, EUA). Optimal transfection was reached after 48 h, and total RNA and proteins were extracted with TRIzol reagent. All siRNA experiments were performed three times. In our results, AGP01 scrambled control cells was named 1C, while AGP01 MYC-silenced was called 1M; ACP02 control cells was named 2C, and its MYC-silenced counterpart was represented by 2M; similarly, ACP03 non-targeting control cells was called 3C and the MYC-silenced cells were named 3M.
Growth protocol Three GC cell lines previously established and characterized by our group were used: AGP01 (obtained from ascitic fluid of an intestinal-type GC), ACP02 (diffuse-type GC) and ACP03 (intestinal-type GC). Cell lines were cultured in DMEM medium (Gibco/Invitrogen, Germany) supplemented with 10% fetal bovine serum (Gibco/Invitrogen, Germany), 100 U/ml penicilin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin B. All cultures were maintained in a 5% CO2 air-humidified atmosphere at 37 °C.
Extracted molecule total RNA
Extraction protocol Total mRNA was isolated from gastric cancer cell lines 48h after RNAi transfection using the AllPrep DNA/RNA/Protein Kit (Qiagen, Germany) according to the manufacturer's instructions. Then, mRNA was reverse-transcribed using the High-Capacity cDNA Archive kit according to the manufacturer’s protocol (Life Technologies, USA). The mRNA and cDNA concentration and quality was determined using a NanoDrop spectrophotometer (Kisker, Germany) and 1% agarose gels, respectively. Samples were stored at -80 °C until use.
RNA libraries were prepared for sequencing using standard Ion Torrent protocols
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Ion Torrent PGM
 
Data processing TMAP to map clean reads to gene reference and/or genome reference
Genes expression level are quantified by a software package: Sailfish.
Analysis of DEG between two samples based on the method of the poisson distribution
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include RPKM values for each sample obtained by Sailfish tools and DEG screening results based on poisson distribution.
 
Submission date May 10, 2016
Last update date May 15, 2019
Contact name Daniel Carvalho
E-mail(s) suporte@genone.com.br
Organization name GenOne Biotetechnologies
Street address Caixa Postal 26820
City Rio de Janeiro
State/province Rio de Janeiro
ZIP/Postal code 21875-970
Country Brazil
 
Platform ID GPL17301
Series (1)
GSE81265 Next-Generation Sequencing reveals the effects of MYC silencing in gastric cancer cell lines from northern Brazil
Relations
SRA ERX605679
BioSample SAMN04966268

Supplementary file Size Download File type/resource
GSM2147867_1M.gene.EXP.txt.gz 235.6 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Processed data are available on Series record
Processed data provided as supplementary file
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap